查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1734917

2032 年栓塞顆粒市場預測：按產品、材料、應用、最終用戶和地區進行的全球分析

Embolization Particle Market Forecasts to 2032 - Global Analysis By Product (Radioembolization Spheres, Microspheres, Drug Eluting Beads, Gelfoam Particles, Gelatin Sponge Particles and Other Products), Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球栓塞顆粒市場預計在 2025 年達到 17 億美元，到 2032 年將達到 38 億美元，預測期內的複合年成長率為 12.7%。

栓塞顆粒是一種小型合成或天然材料，用於栓塞術（一種用於故意阻塞血管的醫療程序）。這些顆粒透過導管注入目標血管，以阻斷流向特定區域的血流，例如腫瘤、異常生長或出血部位。限制血液供應可以縮小腫瘤、止血或減少術中出血。常用材料包括聚乙烯醇 (PVA)、微球、明膠海綿和金屬線圈。顆粒大小和材料的選擇取決於臨床目標和目標血管的大小。

根據美國癌症協會2024年1月發布的數據，預計當年美國將診斷出約41,630例新的肝癌病例。

慢性病增多

癌症、心血管疾病和子宮肌瘤等慢性疾病發生率的上升，推動了栓塞顆粒市場的顯著成長。這些疾病通常需要微創手術進行治療，而栓塞顆粒在阻斷異常血流方面發揮關鍵作用。隨著患者對微創、更有針對性且恢復治療方法更快的治療方案的需求不斷成長，對栓塞技術的需求也日益成長。這一趨勢正在推動創新、投資和市場擴張，使栓塞顆粒成為關鍵的治療方案。

栓塞治療高成本

栓塞手術的高昂成本是栓塞顆粒市場成長的主要障礙。高昂的治療費用限制了患者（尤其是在低收入地區）的就醫管道，從而降低了整體需求。此外，由於營運成本高昂，醫療保健提供者可能不願採用這些先進的手術，這進一步阻礙了市場擴張。這為市場進入者設置了障礙，減緩了創新，並限制了可能挽救生命的治療方法的採用。

技術進步

技術進步顯著推動了栓塞顆粒市場的發展，提高了精準度、療效和病患安全性。影像導引輸送系統、生物可吸收顆粒和奈米技術等創新技術實現了微創標標靶治療，縮短了恢復時間，並改善了治療效果。這些突破性技術正在吸引投資，並拓展了腫瘤科、神經科、婦科等領域的臨床應用。隨著醫療保健向個人化醫療轉變，技術主導的栓塞解決方案提供了更高的客製化能力，推動了其在全球範圍內的廣泛應用和市場成長。

嚴格的監管要求

嚴格的監管要求是栓塞顆粒市場發展的一大障礙，核准流程冗長且成本高昂。 FDA 和 EMA 等監管機構要求進行廣泛的臨床試驗並獲得全面的安全數據，這減緩了新產品的上市速度。這些嚴格的標準增加了開發成本，並使合規性變得複雜，尤其對於中小型製造商而言。這些障礙限制了創新，限制了產品的可近性，阻礙了人們及時獲得先進療法，尤其是在新興市場。

COVID-19的影響

新冠疫情嚴重擾亂了栓塞顆粒市場，導致擇期手術延誤，住院人數減少。封鎖和資源重新分配使供應鏈緊張，為生產和分銷帶來了挑戰。這導致勞動力短缺，並阻礙了臨床開發活動。因此，在疫情高峰期，市場成長放緩。然而，隨著醫療體系的調整和擇期手術的恢復，市場有望復甦並繼續擴張。

預計在預測期內，生物分解性材料市場將成長至最大

預計生物分解性材料將在預測期內佔據最大的市場佔有率，因為這些顆粒在達到治療效果後會自然溶解，從而最大限度地降低永久性植入的風險。人們對微創手術的偏好日益成長，以及對生物相容性的認知不斷提高，推動了這項需求。此外，生物分解性材料的進步提高了治療的精準度和術後恢復，使其成為栓塞顆粒產業技術創新的主要驅動力和催化劑。

預計在預測期內，神經病學領域將以最高的複合年成長率成長。

由於動靜脈畸形等神經血管疾病的發生率上升，預計神經內科領域將在預測期內達到最高成長率。微創手術的進步以及人們對神經系統疾病認知的不斷提高，刺激了對精準栓塞解決方案的需求。醫院和診所擴大採用栓塞顆粒進行有效且有針對性的治療，從而改善患者的治療效果。神經內科領域的強勁需求將繼續對全球栓塞技術市場的擴張、創新和投資產生積極影響。

佔比最大的地區：

在預測期內，由於先進介入放射學手術的普及，亞太地區預計將佔據最大的市場佔有率。世界各國政府都優先考慮微創手術，這推動了栓塞治療的需求。技術進步和醫療旅遊業的蓬勃發展也促進了市場擴張。中國、印度和東南亞等新興經濟體正在推動改善患者預後、縮短復原時間並提供經濟高效的醫療解決方案。

複合年成長率最高的地區：

由於微創技術的日益普及以及介入放射技術的進步，預計北美地區在預測期內的複合年成長率最高。醫療支出和報銷政策的不斷增加進一步推動了市場的成長。領先的公司正在投資研發，以提高治療的有效性和安全性。這些進步正在改善患者的治療效果，並加速治療需求的成長，從而鞏固該地區在全球栓塞技術領域的領導地位。

免費客製化服務：

訂閱此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球栓塞顆粒市場（按產品）

  • 放射栓塞球
  • 微球
  • 藥物釋放型珠（DEB）
  • 明膠海綿顆粒
  • 明膠海綿顆粒
  • 液體栓子
  • 聚乙烯醇（PVA）顆粒
  • 其他產品

6. 全球栓塞顆粒市場（依材料）

  • 生物分解性
  • 生物分解性

7. 全球栓塞顆粒市場（依應用）

  • 腫瘤學
  • 泌尿系統
  • 神經病學
  • 周邊血管疾病
  • 其他用途

8. 全球栓塞顆粒市場（依最終用戶）

  • 醫院
  • 門診手術中心
  • 診所
  • 其他最終用戶

9. 全球栓塞顆粒市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Cook Medical Inc.
  • Sirtex Medical Limited
  • BTG plc
  • Stryker Corporation
  • Penumbra, Inc.
  • Johnson & Johnson
  • Guerbet Group
  • Kaneka Corporation
  • Interface BIOmaterials BV
  • HENGRUI Medical
  • Alicon
Product Code: SMRC29554

According to Stratistics MRC, the Global Embolization Particle Market is accounted for $1.7 billion in 2025 and is expected to reach $3.8 billion by 2032 growing at a CAGR of 12.7% during the forecast period. Embolization particles are small synthetic or natural materials used in a medical procedure called embolization to block blood vessels deliberately. These particles are injected through a catheter into the targeted blood vessels to obstruct blood flow to specific areas, such as tumors, abnormal growths, or areas of bleeding. By restricting blood supply, embolization can shrink tumors, stop hemorrhaging, or reduce blood loss during surgery. Common materials include polyvinyl alcohol (PVA), microspheres, gelatin sponges, or metal coils. The choice of particle size and material depends on the clinical goal and target vessel size.

According to data published by the American Cancer Society, Inc., in January 2024, about 41,630 new liver cancer cases were estimated to be diagnosed in the U.S. that year.

Market Dynamics:

Driver:

Rising Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, cardiovascular conditions, and uterine fibroids is driving significant growth in the embolization particle market. These conditions often require minimally invasive procedures for treatment, where embolization particles play a crucial role in blocking abnormal blood flow. As patient demand increases for less invasive, targeted therapies with faster recovery times, the need for embolization technologies expands. This trend fosters innovation, investment, and market expansion, positioning embolization particles as a key therapeutic solution.

Restraint:

High Cost of Embolization Procedures

The high cost of embolization procedures significantly hinders the growth of the embolization particle market. Expensive treatment prices limit patient accessibility, particularly in low-income regions, reducing overall demand. Additionally, healthcare providers may be reluctant to adopt these advanced procedures due to high operational costs, further stalling market expansion. This creates a barrier for market players, slowing innovation and limiting the adoption of potentially life-saving treatments.

Opportunity:

Technological Advancements

Technological advancements are significantly driving the embolization particle market by enhancing precision, efficacy, and patient safety. Innovations such as image-guided delivery systems, bioresorbable particles, and nanotechnology enable targeted therapy with minimal invasiveness, reducing recovery time and improving outcomes. These breakthroughs attract investment and expand clinical applications across oncology, neurology, and gynecology. As healthcare shifts toward personalized medicine, technology-driven embolization solutions offer superior customization, boosting adoption and market growth globally.

Threat:

Stringent Regulatory Requirements

Stringent regulatory requirements significantly hinder the embolization particle market by imposing lengthy and costly approval processes. Regulatory bodies like the FDA and EMA demand extensive clinical trials and comprehensive safety data, delaying market entry for new products. These rigorous standards increase development costs and complicate compliance, particularly for small and mid-sized manufacturers. Such barriers restrict innovation, limit product availability, and impede timely access to advanced treatments, especially in emerging markets.

Covid-19 Impact

The COVID-19 pandemic significantly disrupted the embolization particle market, leading to delays in elective procedures and reduced hospital admissions. Lockdowns and resource reallocation strained supply chains, causing manufacturing and distribution challenges. This resulted in workforce shortages and hindered clinical development activities. Consequently, the market experienced a slowdown in growth during the peak of the pandemic. However, as healthcare systems adapt and elective procedures resume, the market is poised for recovery and continued expansion.

The biodegradable segment is expected to be the largest during the forecast period

The biodegradable segment is expected to account for the largest market share during the forecast period as these particles naturally dissolve after achieving their therapeutic effect, minimizing risks associated with permanent implants. Growing preference for minimally invasive procedures and increasing awareness of biocompatibility are fueling demand. Additionally, advancements in biodegradable materials enhance treatment precision and post-procedural recovery, positioning this segment as a key growth driver and innovation catalyst within the embolization particle industry.

The neurology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurology segment is predicted to witness the highest growth rate, due to rising incidences of neurovascular disorders such as arteriovenous malformations. Advancements in minimally invasive procedures and increased awareness of neurological conditions have spurred demand for precise embolization solutions. Hospitals and clinics are increasingly adopting embolization particles for effective, targeted treatments, enhancing patient outcomes. This strong demand from the neurology field continues to positively impact market expansion, innovation, and investment in embolic technologies globally.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to improved access to advanced interventional radiology procedures. Governments are prioritizing minimally invasive treatments, boosting demand for embolization therapies. Technological advancements and expanding medical tourism further contribute to market expansion. This positive momentum is enhancing patient outcomes, reducing recovery times, and promoting cost-effective healthcare solutions across rapidly developing economies like China, India, and Southeast Asia.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising adoption of minimally invasive procedures, and technological advancements in interventional radiology. Growing healthcare expenditure and supportive reimbursement policies further drive market growth. Major players are investing in research and development, enhancing treatment efficacy and safety. This progress fosters better patient outcomes, accelerates procedural demand, and strengthens the region's leadership in global embolization technologies.

Key players in the market

Some of the key players profiled in the Embolization Particle Market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems, Inc., Cook Medical Inc., Sirtex Medical Limited, BTG plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, Guerbet Group, Kaneka Corporation, Interface BIOmaterials B.V., HENGRUI Medical and Alicon.

Key Developments:

In February 2025, Medtronic and Philips have partnered to enhance the capabilities of over 300 clinicians in India by providing advanced training in structural heart imaging. This collaboration focuses on equipping cardiologists and radiologists with expertise in multi-modality imaging techniques, particularly echocardiography (echo) and Magnetic Resonance Imaging (MRI), to improve the diagnosis and treatment of structural heart diseases, especially among End-Stage Renal Disease (ESRD) patients.

In July 2024, Medtronic and SWIZTON Medcare have inaugurated their first collaborative vein clinic at Aveksha Hospital in Singapura, Bengaluru. This facility aims to provide accessible and advanced treatments for varicose veins, a condition affecting approximately 20% of adults globally.

Products Covered:

  • Radioembolization Spheres
  • Microspheres
  • Drug Eluting Beads (DEBs)
  • Gelfoam Particles
  • Gelatin Sponge Particles
  • Liquid Embolics
  • Polyvinyl Alcohol (PVA) Particles
  • Other Products

Materials Covered:

  • Biodegradable
  • Non-biodegradable

Applications Covered:

  • Oncology
  • Urology
  • Neurology
  • Peripheral Vascular Disease
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Embolization Particle Market, By Product

  • 5.1 Introduction
  • 5.2 Radioembolization Spheres
  • 5.3 Microspheres
  • 5.4 Drug Eluting Beads (DEBs)
  • 5.5 Gelfoam Particles
  • 5.6 Gelatin Sponge Particles
  • 5.7 Liquid Embolics
  • 5.8 Polyvinyl Alcohol (PVA) Particles
  • 5.9 Other Products

6 Global Embolization Particle Market, By Material

  • 6.1 Introduction
  • 6.2 Biodegradable
  • 6.3 Non-biodegradable

7 Global Embolization Particle Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Urology
  • 7.4 Neurology
  • 7.5 Peripheral Vascular Disease
  • 7.6 Other Applications

8 Global Embolization Particle Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Clinics
  • 8.5 Other End Users

9 Global Embolization Particle Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Boston Scientific Corporation
  • 11.2 Medtronic plc
  • 11.3 Terumo Corporation
  • 11.4 Merit Medical Systems, Inc.
  • 11.5 Cook Medical Inc.
  • 11.6 Sirtex Medical Limited
  • 11.7 BTG plc
  • 11.8 Stryker Corporation
  • 11.9 Penumbra, Inc.
  • 11.10 Johnson & Johnson
  • 11.11 Guerbet Group
  • 11.12 Kaneka Corporation
  • 11.13 Interface BIOmaterials B.V.
  • 11.14 HENGRUI Medical
  • 11.15 Alicon

List of Tables

  • Table 1 Global Embolization Particle Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 4 Global Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 5 Global Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 6 Global Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 7 Global Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 8 Global Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 9 Global Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 10 Global Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 11 Global Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 12 Global Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 13 Global Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 14 Global Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 16 Global Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 17 Global Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 18 Global Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 19 Global Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 20 Global Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 21 Global Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 22 Global Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 23 Global Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 24 Global Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 25 North America Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 26 North America Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 27 North America Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 28 North America Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 29 North America Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 30 North America Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 31 North America Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 32 North America Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 33 North America Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 34 North America Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 35 North America Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 36 North America Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 37 North America Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 38 North America Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 39 North America Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 40 North America Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 41 North America Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 42 North America Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 43 North America Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 44 North America Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 45 North America Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 46 North America Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 47 North America Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 48 North America Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 49 Europe Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 50 Europe Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 51 Europe Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 52 Europe Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 53 Europe Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 54 Europe Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 55 Europe Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 56 Europe Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 57 Europe Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 58 Europe Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 59 Europe Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 60 Europe Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 61 Europe Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 62 Europe Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 63 Europe Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 64 Europe Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 65 Europe Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 66 Europe Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 67 Europe Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 68 Europe Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 69 Europe Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 70 Europe Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 71 Europe Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 72 Europe Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 73 Asia Pacific Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 74 Asia Pacific Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 75 Asia Pacific Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 76 Asia Pacific Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 77 Asia Pacific Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 78 Asia Pacific Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 79 Asia Pacific Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 80 Asia Pacific Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 81 Asia Pacific Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 82 Asia Pacific Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 83 Asia Pacific Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 84 Asia Pacific Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 85 Asia Pacific Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 86 Asia Pacific Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 87 Asia Pacific Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 88 Asia Pacific Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 89 Asia Pacific Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 90 Asia Pacific Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 91 Asia Pacific Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 92 Asia Pacific Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 93 Asia Pacific Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 94 Asia Pacific Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 95 Asia Pacific Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 96 Asia Pacific Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 97 South America Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 98 South America Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 99 South America Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 100 South America Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 101 South America Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 102 South America Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 103 South America Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 104 South America Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 105 South America Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 106 South America Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 107 South America Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 108 South America Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 109 South America Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 110 South America Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 111 South America Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 112 South America Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 113 South America Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 114 South America Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 115 South America Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 116 South America Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 117 South America Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 118 South America Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 119 South America Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 120 South America Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 121 Middle East & Africa Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 122 Middle East & Africa Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 123 Middle East & Africa Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 124 Middle East & Africa Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 125 Middle East & Africa Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 126 Middle East & Africa Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 127 Middle East & Africa Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 128 Middle East & Africa Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 129 Middle East & Africa Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 130 Middle East & Africa Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 131 Middle East & Africa Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 132 Middle East & Africa Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 133 Middle East & Africa Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 134 Middle East & Africa Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 135 Middle East & Africa Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 136 Middle East & Africa Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 137 Middle East & Africa Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 138 Middle East & Africa Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 139 Middle East & Africa Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 140 Middle East & Africa Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 141 Middle East & Africa Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 142 Middle East & Africa Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 143 Middle East & Africa Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 144 Middle East & Africa Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)